Revolutional Therapy for Metabolic Syndrome
The First And Only Multitarget Drug Against Metabolic Syndrome And Its Related Diseases
- One Molecule Combating Multiple Targets – Type 2 Diabetes, Organ Fibrosis, Non-Alcoholic Fatty Liver Disease, Heart Disease, And Kidney Disease
- More Predictable Pharmacokinetics (Body Reactions) With Prolonged Duration Of Effectiveness
- Oral Administration Prevents The Unpleasantness Of Insulin Injections And Other Complications Associated With The Existing Therapies
- Cost Effective